Mitchell Wallin

7PUBLICATIONS
34CO-AUTHORS
AutoimmunityRegenerative medicine (incl. stem cells)Medical molecular engineering of nucleic acids and proteinsMajor global burdens of diseasePeople with disability
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 13, 2026
Development of a Diagnostic Autoantibody Assay to a Consensus Motif for the Risk Prediction of Epstein-Barr Virus-Related Multiple Sclerosis.

Krista M McCutcheon, Aaron Bodansky, Thomas T Ngo

|Dec 15, 2025
Lipoic Acid for Treatment of Progressive Multiple Sclerosis: A Phase 2 Randomized Clinical Trial.

Rebecca I Spain, M Mateo Paz Soldán, Mark S Freedman

|Oct 20, 2025
Myelin injury precedes axonal injury and symptomatic onset in multiple sclerosis.

Ahmed Abdelhak, Gabriel Cerono, Fahime Sheikhzadeh

|Aug 26, 2020
Initial highly effective therapy for MS: A strong start.

Mitchell T Wallin

|May 02, 2019
Telemedicine and multiple sclerosis: A comprehensive literature review.

Samuel Yeroushalmi, Heidi Maloni, Kathleen Costello

Pageof 2